세계의 임상 의사결정 지원 시스템 시장 : 기회 및 전략(-2034년)
Clinical Decision Support System Global Market Opportunities And Strategies To 2034
상품코드 : 1754838
리서치사 : The Business Research Company
발행일 : 2025년 06월
페이지 정보 : 영문 333 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 임상 의사결정 지원 시스템 시장은 2019년 16억 8,493만 달러로 평가되었으며, 2024년까지 13.00% 이상의 CAGR을 나타냈습니다.

맞춤형 의료에 대한 수요 증가

실적 기간 중, 맞춤형 의료에 대한 수요 증가가 임상 의사결정 지원 시스템 시장 성장을 지지했습니다. 치료 반응을 예측하고 의사가 가장 효과적인 치료법을 선택할 수 있도록 합니다. 예를 들어, 과학자, 환자 및 의료 제공자를 대표하여 환자와 의료 시스템에 도움이 되는 맞춤 의학에 대한 이해와 도입을 촉진하는 미국 기반 단체인 맞춤 의학 연합은 2022년 10월 여러 유형의 암, 유전 희귀 질환 및 다양한 만성 및 전염병 환자를 위한 유전자 검사 제품과 300개 이상의 맞춤 의약품이 시장에 출시되어 있다고 추정했습니다. 또한, 개인 맞춤형 의약품을 옹호하는 미국 기업 PMC(Personalized Medicine Coalition)에 따르면 2022년에는 개인 맞춤형 의약품이 미국 식품의약국 신약 승인의 34%를 차지했으며, 지난 8년간 승인 건수 중 최소 25% 이상을 차지한 바 있습니다.

목차

제1장 주요 요약

제2장 목차

제3장 표 일람

제4장 그림 일람

제5장 보고서 구성

제6장 시장 특징

제7장 주요 시장 동향

제8장 세계의 임상 의사결정 지원 시스템 성장 분석과 전략 분석 프레임워크

제9장 세계의 임상 의사결정 지원 시스템 시장 세분화

제10장 임상 의사결정 지원 시스템 시장 : 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 프로파일

제19장 기타 주요 기업 및 혁신 기업

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병(M&A)

제23장 임상 의사결정 지원 시스템 시장에서의 최근 동향

제24장 기회와 전략

제25장 임상 의사결정 지원 시스템 시장 : 결론 및 제안

제26장 부록

KTH
영문 목차

영문목차

Clinical decision support systems (CDSS) are computer-based tools designed to assist healthcare professionals in making informed clinical decisions by analyzing patient data and providing evidence-based recommendations. These systems are utilized by a wide range of healthcare providers, including physicians, nurses, and allied health professionals, to enhance patient care across various medical settings.

The clinical decision support systems market consists of revenues generated by entities (organizations, sole traders, and partnerships) involved in the development and implementation of these systems. Clinical decision support systems (CDSS) are computer-based programs designed to enhance healthcare delivery by providing clinicians with evidence-based knowledge and patient-specific information at the point of care.

The global clinical decision support systems market was valued at $1,684.93 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 13.00%.

Rising Demand For Personalized Medicine

During the historic period, the rising demand for personalized medicine supported the growth of the clinical decision support systems market. Personalized medicine utilizes genomic data to tailor treatments, and clinical decision support systems (CDSS) enhance this by integrating genetic test results with clinical guidelines. AI-driven CDSS analyzes patient data to predict treatment responses, enabling physicians to select the most effective therapies. This data-driven approach improves precision, ensuring treatments are personalized rather than standardized. For example, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, in 2022, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines will account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the rising demand for personalized medicine drove the growth of the clinical decision support systems market.

Strategic Partnerships Driving Innovation In Clinical Decision Support Systems

Major companies operating in the clinical decision support systems market are adopting a strategic partnerships approach to develop advanced clinical solutions. Strategic partnerships help clinical decision support systems companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the clinical decision support systems industry. For instance, in October 2024, Nordic Consulting Partners, Inc., a US-based healthcare consulting firm specializing in EHR implementation, partnered with BeeKeeperAI, Inc., a US-based healthcare AI company focused on privacy-preserving AI solutions to accelerate AI-driven clinical decision support at the point of care by enabling secure, privacy-preserving access to real-world healthcare data. This collaboration leverages BeeKeeperAI's confidential computing technology and Nordic's deep expertise in healthcare IT and EHR integration to facilitate the development and deployment of AI models without compromising patient privacy. The partnership aims to enhance clinical workflows, improve diagnostic accuracy, and drive better patient outcomes while ensuring compliance with stringent data security regulations.

The global clinical decision support systems market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 76.23% of the total market in 2023.

Clinical Decision Support System Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global clinical decision support System market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for clinical decision support clinical decision support? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The clinical decision support market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider clinical decision support system market; and compares it with other markets.

The report covers the following chapters

Markets Covered:

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Major Market Trends

8 Global Clinical Decision Support Systems Growth Analysis And Strategic Analysis Framework

9 Global Clinical Decision Support Systems Market Segmentation

10 Clinical Decision Support Systems Market, Regional and Country Analysis

11 Asia-Pacific Market

12 Western Europe Market

13 Eastern Europe Market

14 North America Market

15 South America Market

16 Middle East Market

17 Africa Market

18 Competitive Landscape And Company Profiles

19 Other Major And Innovative Companies

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

23 Recent Developments In The Clinical Decision Support Systems market

24 Opportunities And Strategies

25 Clinical Decision Support Systems Market, Conclusions And Recommendations

26 Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기